Solid results at Kimberly-Clark in Q1

• Organic sales rose 5% for Kimberly-Clark (NYSE:KMB) in Q1, including a rise of 11% in developing and emerging markets.
• Volume was up 3%, while pricing and product mix both contributed a percentage point to growth.
• As expected, foreign currency was a major drag with an impact on total revenue of 9%.
• Segment revenue growth: Personal care -3.1% to $2.308, Consumer Tissue -6.8% to $1.574, K-C Professional -0.6% to $795.
• Guidance: The company sees FY15 EPS of $5.60-$5.80 vs. $5.64 consensus.
• Previously: Kimberly-Clark beats by $0.09, beats on revenue